ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/
HRTTicker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Insider trading at ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ (HRT) refers to stock transactions executed by corporate insiders—officers, directors, and shareholders owning more than 10% of the company. Over the past 90 days, 57 insiders have filed 495 transactions totaling $151.9M in trading activity. The most active insider is James D. Carey (Executive), contributing $28.2M across 21 transactions.
ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ insiders are currently net buyers of HRT stock, showing bullish sentiment over the past 90 days. Executives have purchased $110.7M while selling $41.2M, resulting in a positive net flow of $69.5M. This buying activity represents 73% of total transaction volume.
ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ has 57 active insiders who have filed SEC Form 4 transactions in the past 90 days. James D. Carey (Executive) leads with 21 transactions totaling $28.2M. Gis Holdings Llc Rjc (Executive) follows with 22 transactions worth $16.1M. Open-market purchases require insiders to invest their own capital, demonstrating genuine conviction.
The Insider Alignment Score measures the ratio of buying to selling activity on a 0-100 scale. ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/'s current score of 73/100 indicates bullish insider sentiment. Scores above 60 suggest insiders are accumulating shares faster than selling, reflecting $110.7M in purchases versus $41.2M in sales.
The most recent insider transaction occurred on Jun 28, 2024, when P. Abramo Guy (Executive) disposed of 337,477 shares at $0.00 per share for $0. This appears to be a discretionary trade.
Based on SEC Form 4 filings from the past 90 days, HRT insider trading sentiment is currently bullish with an Alignment Score of 73/100. The net insider flow of $69.5M reflects accumulation, with 73% of volume being purchases.
SEC Form 4 is the primary disclosure mechanism for insider trading at publicly traded companies like ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/. Corporate insiders must file within two business days of any transaction, making it one of the most timely sources of executive sentiment. At HRT, we track all Form 4 filings—currently showing 495 transactions from 57 insiders over 90 days.
A 10b5-1 plan allows ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ executives to pre-schedule stock sales when they don't possess material non-public information. At HRT, approximately 0% of recent transactions are 10b5-1 trades. Most trading activity at HRT appears discretionary, making insider signals more meaningful.
You can monitor ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ (HRT) insider trading activity on this page, which updates within hours of new SEC Form 4 filings. We track all 57 active insiders and provide real-time transaction feeds, the Alignment Score, 10b5-1 vs. discretionary breakdowns, and direct links to SEC EDGAR filings.
Insider trading at ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ (HRT) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of shares. These individuals must report trades to the SEC within two business days. Currently, 57 insiders are actively trading HRT stock, having executed 495 transactions in the past 90 days. The most active insider is James D. Carey (Executive), with 21 transactions totaling $28.2M.
Our Alignment Score measures the ratio of insider buying to selling on a scale of 0-100. A score above 70 indicates strong bullish sentiment, while below 30 suggests bearish activity. ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/'s current score of 73/100 indicates strong bullish sentiment with executives accumulating shares. This is calculated from $110.7M in purchases versus $41.2M in sales over 90 days, resulting in a net flow of $69.5M.
SEC Form 4 filings are mandatory reports that ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ insiders must submit within 2 business days. Each filing includes the insider's name, relationship, transaction type, shares, and price. Transaction codes: P (purchase), S (sale), A (award), M (option exercise), G (gift). At HRT, the most common type is "D" with 49 occurrences. The most recent Form 4 was filed on Jun 28, 2024 by P. Abramo Guy.
Rule 10b5-1 allows corporate insiders to establish pre-scheduled trading plans when they don't possess material non-public information. At ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/, approximately 0% of recent transactions are executed under 10b5-1 plans, while 100% appear to be discretionary trades. The low percentage means most insider activity at HRT represents discretionary decisions with more informational value.
Track every insider move.
Before the market reacts.
Set alerts for ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ and 40,000+ other insiders.